This Stock Is a Patient Investor’s Dream Buy at New 52-Week Lows

Lennox International has fallen 47% from its peak and hit a new 52-week low, but its growing commercial business, strong free cash flow, shareholder returns, and reasonable valuation make it a compelling long-term value opportunity for patient investors.